Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genvec
Biotech
Intrexon to buy floundering GenVec for gene delivery tech
Intrexon is set to buy GenVec in an all-stock deal to add a gene delivery platform to its arsenal.
Nick Paul Taylor
Jan 25, 2017 4:45am
GenVec: We’re not a victim of Novartis R&D cuts
Sep 1, 2016 7:31am
GenVec, encamped in penny-stock territory, risks Nasdaq delisting
Aug 26, 2016 4:52am